PortfoliosLab logoPortfoliosLab logo
GM vs. ABBV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GM vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in General Motors Company (GM) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GM achieves a 0.68% return, which is significantly lower than ABBV's 1.30% return. Over the past 10 years, GM has underperformed ABBV with an annualized return of 13.16%, while ABBV has yielded a comparatively higher 19.10% annualized return.


GM

1D
0.80%
1M
5.05%
YTD
0.68%
6M
1.21%
1Y
69.06%
3Y*
30.69%
5Y*
6.65%
10Y*
13.16%

ABBV

1D
1.32%
1M
8.05%
YTD
1.30%
6M
3.65%
1Y
23.06%
3Y*
22.39%
5Y*
18.94%
10Y*
19.10%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GM vs. ABBV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
GM
General Motors Company
0.68%54.24%49.84%7.92%-42.36%40.80%15.16%14.02%-15.06%22.51%
ABBV
AbbVie Inc.
1.30%33.08%18.86%-0.23%24.01%32.43%27.72%1.47%-0.96%60.07%

Correlation

The correlation between GM and ABBV is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (5Y)
Calculated over the trailing 5-year period

0.15

Correlation (10Y)
Calculated over the trailing 10-year period

0.21

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2013

0.23

Fundamentals

Market Cap

GM:

$74.93B

ABBV:

$403.99B

EPS

GM:

$2.68

ABBV:

$2.05

PE Ratio

GM:

30.41

ABBV:

110.96

PS Ratio

GM:

0.42

ABBV:

6.43

PB Ratio

GM:

1.20

ABBV:

14.69

Total Revenue (TTM)

GM:

$184.62B

ABBV:

$62.82B

Gross Profit (TTM)

GM:

$11.25B

ABBV:

$46.15B

EBITDA (TTM)

GM:

$13.56B

ABBV:

$17.96B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GM vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GM
GM Risk / Return Rank: 8989
Overall Rank
GM Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
GM Sortino Ratio Rank: 8989
Sortino Ratio Rank
GM Omega Ratio Rank: 8888
Omega Ratio Rank
GM Calmar Ratio Rank: 9090
Calmar Ratio Rank
GM Martin Ratio Rank: 8989
Martin Ratio Rank

ABBV
ABBV Risk / Return Rank: 6868
Overall Rank
ABBV Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 6666
Sortino Ratio Rank
ABBV Omega Ratio Rank: 6565
Omega Ratio Rank
ABBV Calmar Ratio Rank: 6868
Calmar Ratio Rank
ABBV Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GM vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for General Motors Company (GM) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GMABBVDifference
Sharpe ratioReturn per unit of total volatility

+1.02

Sortino ratioReturn per unit of downside risk

+1.48

Omega ratioGain probability vs. loss probability

1.37

1.18

+0.20

Calmar ratioReturn relative to maximum drawdown

4.21

1.29

+2.92

Martin ratioReturn relative to average drawdown

10.37

2.88

+7.49

GM vs. ABBV - Sharpe Ratio Comparison

The current GM Sharpe Ratio is 1.94, which is higher than the ABBV Sharpe Ratio of 0.92. The chart below compares the historical Sharpe Ratios of GM and ABBV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GM vs. ABBV - Drawdown Comparison

The maximum GM drawdown since its inception was -59.96%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for GM and ABBV.


Loading charts...

Drawdown Indicators


GMABBVDifference

Max Drawdown

Largest peak-to-trough decline

-59.96%

-45.09%

-14.87%

Max Drawdown (1Y)

Largest decline over 1 year

-16.00%

-17.32%

+1.32%

Max Drawdown (3Y)

Largest decline over 3 years

-34.02%

-20.74%

-13.28%

Max Drawdown (5Y)

Largest decline over 5 years

-58.96%

-21.92%

-37.04%

Max Drawdown (10Y)

Largest decline over 10 years

-59.96%

-45.09%

-14.87%

Current Drawdown

Current decline from peak

-5.22%

-4.60%

-0.62%

Average Drawdown

Average peak-to-trough decline

-21.51%

-10.71%

-10.80%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.48%

7.75%

-1.27%

Volatility

GM vs. ABBV - Volatility Comparison

General Motors Company (GM) has a higher volatility of 11.54% compared to AbbVie Inc. (ABBV) at 6.10%. This indicates that GM's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GMABBVDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.54%

6.10%

+5.44%

Volatility (6M)

Calculated over the trailing 6-month period

23.80%

17.85%

+5.95%

Volatility (1Y)

Calculated over the trailing 1-year period

34.80%

24.31%

+10.49%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

36.65%

22.89%

+13.76%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

36.95%

25.73%

+11.22%

Dividends

GM vs. ABBV - Dividend Comparison

GM's dividend yield for the trailing twelve months is around 0.81%, less than ABBV's 2.96% yield.


PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.
2.96%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
GM
General Motors Company
0.81%0.70%0.90%1.00%0.54%0.00%0.91%4.15%4.54%3.71%4.36%4.06%

Financials

GM vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between General Motors Company and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B20.00B30.00B40.00B50.00B20222023202420252026
43.62B
15.00B
(GM) Total Revenue
(ABBV) Total Revenue
Values in USD except per share items

GM vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between General Motors Company and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20222023202420252026
11.5%
83.5%
Portfolio components
GM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, General Motors Company reported a gross profit of 5.00B and revenue of 43.62B. Therefore, the gross margin over that period was 11.5%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.

GM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, General Motors Company reported an operating income of 2.93B and revenue of 43.62B, resulting in an operating margin of 6.7%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.

GM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, General Motors Company reported a net income of 2.63B and revenue of 43.62B, resulting in a net margin of 6.0%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.


Frequently Asked Questions


GM and ABBV have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

GM has higher volatility (11.54%) compared to ABBV (6.10%). In terms of maximum drawdown, GM dropped -59.96% vs ABBV's -45.09%.

GM currently has the higher Sharpe Ratio (1.94 vs 0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GM and ABBV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer